Search by Drug Name or NDC

    NDC 00074-1539-03 Humira Details

    Humira

    Humira is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AbbVie Inc.. The primary component is .

    Product Information

    NDC 00074-1539
    Product ID 0074-1539_17d70a36-5bb6-43f0-add4-490aafac7ce3
    Associated GPIs 6627001500F450
    GCN Sequence Number 078672
    GCN Sequence Number Description adalimumab PEN IJ KIT 80 MG-40MG SUBCUT
    HIC3 S2J
    HIC3 Description ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR
    GCN 44954
    HICL Sequence Number 024800
    HICL Sequence Number Description ADALIMUMAB
    Brand/Generic Brand
    Proprietary Name Humira
    Proprietary Name Suffix n/a
    Non-Proprietary Name Adalimumab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name AbbVie Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125057
    Listing Certified Through 2024-12-31

    Package

    NDC 00074-1539-03 (00074153903)

    NDC Package Code 0074-1539-03
    Billing NDC 00074153903
    Package 3 KIT in 1 CARTON (0074-1539-03) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE
    Marketing Start Date 2017-04-21
    NDC Exclude Flag N
    Pricing Information N/A